e-learning
resources
Virtual 2020
Pre-Congress Content
Respiratory viruses in the "pre COVID-19" era
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influenza point-of-care testing: what is the point?
M. Maycock (Glasgow (Glasgow), United Kingdom), E. Goldstein (Glasgow (Glasgow), United Kingdom), W. Harvey (Glasgow (Glasgow), United Kingdom), E. Bellhouse (Glasgow (Glasgow), United Kingdom), S. Htwe (Glasgow (Glasgow), United Kingdom), R. Gunson (Glasgow (Glasgow), United Kingdom), B. Choo-Kang (Glasgow (Glasgow), United Kingdom)
Source:
Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Session:
Respiratory viruses in the "pre COVID-19" era
Session type:
E-poster session
Number:
2378
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Maycock (Glasgow (Glasgow), United Kingdom), E. Goldstein (Glasgow (Glasgow), United Kingdom), W. Harvey (Glasgow (Glasgow), United Kingdom), E. Bellhouse (Glasgow (Glasgow), United Kingdom), S. Htwe (Glasgow (Glasgow), United Kingdom), R. Gunson (Glasgow (Glasgow), United Kingdom), B. Choo-Kang (Glasgow (Glasgow), United Kingdom). Influenza point-of-care testing: what is the point?. 2378
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Influenza: still a threat?
Source: Annual Congress 2008 - Infection year in review
Year: 2008
Respiratory viral point of care testing (POCT) allows improved infection control and bed management during an influenza outbreak
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Influenza surveillance and vaccination: new developments
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017
A rapid test for screening, monitoring and follow up for influenza A H1N1
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Diagnostic and economic evaluation of a point-of-care test for respiratory syncytial virus
Source: ERJ Open Res, 6 (3) 00018-2020; 10.1183/23120541.00018-2020
Year: 2020
Indicator condition-guided HIV testing in Europe: a step forward to HIV control
Source: Eur Respir J 2013; 42: 572-575
Year: 2013
Another aspect of COVID pandemic: where has all the Flu gone?
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Remote consultations: From use during COVID-19 outbreak to routine practice?
Source: Sleep and Breathing Conference 2021
Year: 2021
Novel capsaicin challenge methodology: a new diagnostic endpoint?
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020
Practical exercise: respiratory pandemic scenario (ISARIC/ERS)
Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic
Year: 2018
The new era of diagnostics: will it ever start?
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019
Tuberculosis diagnostics: which target product profiles should be prioritised?
Source: Eur Respir J 2014; 44: 537-540
Year: 2014
Trends of testing for and diagnosis of a
1
-antitrypsin deficiency in the UK: more testing is needed
Source: Eur Respir J, 52 (1) 1800360; 10.1183/13993003.00360-2018
Year: 2018
Low-technology exercise tests: an alternative to high-technology tests?
Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients
Year: 2009
Clinical application of an intelligent oropharyngeal swab robot: implication for the COVID-19 pandemic
Source: Eur Respir J, 56 (2) 2001912; 10.1183/13993003.01912-2020
Year: 2020
Testing for Alfa1-antitrypsin deficiency: is phenotyping enough?
Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep
Year: 2019
Blood biomarkers: ready for practice?
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
New-entrant screening for tuberculosis at port of entry in the U.K.: Is it time to change policy?
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012
Development of RSV vaccines: where are we?
Source: International Congress 2019 – Respiratory syncytial virus infections throughout life
Year: 2019
Late Breaking Abstract - “Home-made” CPAP system during COVID-19 pandemic. ¿Is it helpful?
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept